In addition, while the number of cases of lung cancer diagnosed in Kentucky were drawn from a population-based cancer registry, the analysis of erlotinib prescribing and EGFR testing was conducted with a linked insurance claims database. The gene discussed is EGFR; the disease is lung cancer.